Chronic Kidney Disease and Post-Percutaneous Coronary Intervention Mortality in Patients With Left Main and

Neil Yager1, Krishnakumar Hongalgi1, Mikhail Torosoff1

  • 1Division of Cardiology and Nephrology, Albany Medical College, Albany, New York.

Insights

Patients with chronic kidney disease (CKD) face higher mortality after nonemergent percutaneous coronary intervention (PCI). Advanced CKD significantly predicts death following PCI for left main coronary artery disease.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Interventional Cardiology

Background:

  • Chronic kidney disease (CKD) patients are underrepresented in coronary artery disease (CAD) research.
  • Investigating CKD's impact on CAD management outcomes is crucial.

Purpose of the Study:

  • To analyze the effect of CKD on outcomes of elective percutaneous coronary intervention (PCI) for left main or left main-equivalent coronary artery disease.

Main Methods:

  • Analysis of 2,956 elective PCI cases from the New York State Percutaneous Coronary Intervention Registry in 2015.
  • Inclusion criteria: stable left main or equivalent CAD, elective PCI.
  • Exclusion criteria: acute coronary syndromes, shock, prior coronary artery bypass surgery.

Main Results:

  • Stage 4 or 5 CKD was a significant predictor of post-PCI mortality.
  • Congestive heart failure and left main disease also predicted mortality.
  • Outcomes were compared across different degrees of CKD.

Conclusions:

  • Advanced CKD is associated with significantly increased mortality after nonemergent PCI.
  • Findings highlight the heightened risk for CKD patients undergoing PCI for complex CAD.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
130
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
70
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
56
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
67
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53